Rising Adoption of Targeted Oncology Therapies Boosts North America ADC Market
Strategic collaborations among pharmaceutical manufacturers, biotechnology companies, and research organizations are creating opportunities for the North American ADC market. These partnerships are accelerating clinical development and supporting innovation in targeted cancer treatments.
Market Overview
The Antibody Drug Conjugates Market is projected to reach US$38,077.45 million by 2031...